Literature DB >> 2480347

Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. Evidence for a direct association with the high conductance calcium-activated potassium channel.

J Vázquez1, P Feigenbaum, G Katz, V F King, J P Reuben, L Roy-Contancin, R S Slaughter, G J Kaczorowski, M L Garcia.   

Abstract

Charybdotoxin (ChTX), a peptidyl inhibitor of the high conductance Ca2+-activated K+ channel (PK,Ca), has been radiolabeled to high specific activity with 125I, and resulting derivatives have been well separated. The monoiodotyrosine adduct blocks PK,Ca in vascular smooth muscle with slightly reduced potency compared with the native peptide under defined experimental conditions. [125I]ChTX, representing this derivative, binds specifically and reversibly to a single class of sites in sarcolemmal membrane vesicles prepared from bovine aortic smooth muscle. These sites display a Kd of 100 pM for the iodinated toxin, as determined by either equilibrium or kinetic binding analyses. Binding site density is about 500 fmol/mg of protein in isolated membranes. The addition of low digitonin concentrations to disrupt the vesicle permeability barrier increases the maximum receptor concentration to 1.5 pmol/mg of protein, correlating with the observations that ChTX binds only at the external pore of PK,Ca and that the membrane preparation is of mixed polarity. Competition studies with ChTX yield a Ki of about 20 pM for native toxin. Binding of [125I]ChTX is modulated by ionic strength as well as by metal ions that are known to interact with PK,Ca. Moreover, tetraethylammonium ion, which blocks PK,Ca with moderately high affinity when applied at the external membrane surface, inhibits [125I]ChTX binding in an apparently competitive fashion with a Ki similar to that found for channel inhibition. In marked contrast, agents that do not inhibit PK,Ca in smooth muscle (e.g. tetrabutylammonium ion, other toxins homologous with ChTX, and pharmacological agents that modulate the activity of dissimilar ion channels) have no effect on [125I]ChTX binding in this tissue. Taken together, these results suggest that the binding sites for ChTX which are present in vascular smooth muscle are directly associated with PK,Ca, thus identifying [125I]ChTX as a useful probe for elucidating the biochemical properties of these channels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Use of toxins to study potassium channels.

Authors:  M L Garcia; A Galvez; M Garcia-Calvo; V F King; J Vazquez; G J Kaczorowski
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

2.  Evaluation of the relaxant effects of SCA40, a novel charybdotoxin-sensitive potassium channel opener, in guinea-pig isolated trachealis.

Authors:  F Laurent; A Michel; P A Bonnet; J P Chapat; M Boucard
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  Functional unit size of the charybdotoxin receptor in smooth muscle.

Authors:  M Garcia-Calvo; H G Knaus; M L Garcia; G J Kaczorowski; E S Kempner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 4.  Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?

Authors:  P Pickkers; M Schachter; A D Hughes; M D Feher; P S Sever
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 5.  High-conductance calcium-activated potassium channels; structure, pharmacology, and function.

Authors:  G J Kaczorowski; H G Knaus; R J Leonard; O B McManus; M L Garcia
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

6.  Ca(2+)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins.

Authors:  C Brugnara; C C Armsby; L De Franceschi; M Crest; M F Euclaire; S L Alper
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

7.  Cardiovascular effects of SCA40, a novel potassium channel opener, in rats.

Authors:  A Michel; F Laurent; J Bompart; K Hadj-Kaddour; J P Chapat; M Boucard; P A Bonnet
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Toxin pharmacology of the large-conductance Ca(2+)-activated K+ channel in the apical membrane of rabbit proximal convoluted tubule in primary culture.

Authors:  M Tauc; P Congar; V Poncet; J Merot; C Vita; P Poujeol
Journal:  Pflugers Arch       Date:  1993-10       Impact factor: 3.657

9.  Characterization of Ca(2+)-activated 86Rb+ fluxes in rat C6 glioma cells: a system for identifying novel IKCa-channel toxins.

Authors:  F A de-Allie; S R Bolsover; A V Nowicky; P N Strong
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart.

Authors:  J D McLeod; P J Piper
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.